APA

Stein R., Gupta P., Chen X., Cardillo T. M., Furman R. R., Chen S., Chang C. & Goldenberg D. M. (20100709). Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways. : Blood.

Chicago

Stein Rhona, Gupta Pankaj, Chen Xiaochuan, Cardillo Thomas M, Furman Richard R, Chen Susan, Chang Chien-Hsing and Goldenberg David M. 20100709. Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways. : Blood.

Harvard

Stein R., Gupta P., Chen X., Cardillo T. M., Furman R. R., Chen S., Chang C. and Goldenberg D. M. (20100709). Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways. : Blood.

MLA

Stein Rhona, Gupta Pankaj, Chen Xiaochuan, Cardillo Thomas M, Furman Richard R, Chen Susan, Chang Chien-Hsing and Goldenberg David M. Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways. : Blood. 20100709.